文献速递头颈部肿瘤放疗

口咽癌放疗中GTV缩小分析:对自适应放疗的启示

Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy.
PubMed 文献 · Radiother Oncol · 2016-11-18

本研究纳入8例接受放化疗的口咽癌患者,在原发肿瘤边缘植入基准标记,通过每日CBCT和分次MRI比较标记位移与GTV表面位移。结果显示MRI测得的GTV表面位移大于标记位移,且部分标记与GTV表面距离增大,提示GTV缩小可能部分源于肿瘤溶解而非真正收缩,基于GTV缩小的自适应计划可能不安全。

要点

  • MRI显示的GTV表面位移大于基准标记位移,平均差异第3周为0.1cm。
  • 第3周时33%的标记与GTV表面距离增加>0.3cm,10%增加>0.5cm。
  • 基于GTV缩小的自适应放疗可能导致微观病灶欠剂量,调整至清晰解剖边界可能安全。

核心结论

  • 基于MRI中GTV缩小的自适应放疗可能不安全,因为至少部分GTV可能正在溶解而非真正收缩。
  • 根据清晰解剖边界进行调整可能是安全的。

研究设计与样本

  • 纳入8例接受放化疗的口咽癌患者,治疗前在原发肿瘤边缘植入基准标记(0.035×0.2cm²,n=40)。
  • 所有患者接受计划CT、每日锥形束CT(CBCT)以及治疗前、第3周和第6周的MRI。
  • 比较CBCT上标记位移与MRI上局部GTV表面位移,并测量治疗期间标记相对于GTV表面的位移。

主要发现

  • MRI测得的GTV表面位移大于基准标记测得的位移,第3周平均差异为0.1cm。
  • 治疗期间第3周,MRI上标记与GTV表面距离增加>0.3cm者占33%,增加>0.5cm者占10%。
  • MRI显示的GTV缩小速度快于标记所代表的周围组织。

临床怎么用

  • 自适应放疗中应谨慎基于GTV缩小进行靶区缩减,以免微观病灶欠剂量。
  • 可考虑根据清晰解剖边界进行调整而非仅依据GTV缩小。

局限性

  • 样本量较小(8例患者)。
  • 基准标记作为GTV边缘周围组织行为的替代指标可能存在局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Adaptive field size reduction based on gross tumor volume (GTV) shrinkage imposes risk on coverage. Fiducial markers were used as surrogate for behavior of tissue surrounding the GTV edge to assess this risk by evaluating if GTVs during treatment are dissolving or actually shrinking. MATERIALS AND METHODS: Eight patients with oropharyngeal tumors treated with chemo-radiation were included. Before treatment, fiducial markers (0.035×0.2cm2, n=40) were implanted at the edge of the primary tumor. All patients underwent planning-CT, daily cone beam CT (CBCT) and MRIs (pre-treatment, weeks 3 and 6). Marker displacement on CBCT was compared to local GTV surface displacement on MRIs. Additionally, marker displacement relative to the GTV surfaces during treatment was measured. RESULTS: GTV surface displacement derived from MRI was larger than derived from fiducial markers (average difference: 0.1cm in week 3). During treatment, the distance between markers and GTV surface on MRI in week 3 increased in 33%>0.3cm and in 10%>0.5cm. The MRI-GTV shrank faster than the surrounding tissue represented by the markers, i.e. adapting to GTV shrinkage may cause under-dosage of microscopic disease. CONCLUSIONS: We showed that adapting to primary tumor GTV shrinkage on MRI mid-treatment is potentially not safe since at least part of the GTV is likely to be dissolving. Adjustment to clear anatomical boundaries, however, may be done safely.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Hamming-Vrieze O, van Kranen SR, Heemsbergen WD, et al. Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy. Radiother Oncol. 2016. PMID: 27866848. doi:10.1016/j.radonc.2016.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。